Health News

Weakness of certain types of cancer may lead to targeted therapy and provide the key to effective treatment, a new study suggests. An international consortium of researchers has shown that an investigational drug, Olaparib, can reduce the size of tumors in women with advanced hereditary ovarian cancer with BRCA gene mutations…

Read more

Filed under: Women's Health
Tags: Breast Cancer, cancer, Drug, gene, Tumor, Women's Health

Related posts

• FDA Approves New Test To Help Determine If Breast Cancer Patients Are Candidates For Herceptin Treatment (0)
  The U.S. Food and Drug Administration today approved a new genetic test that will help health care professionals determine if women with breast cancer are HER2-positive and, therefore, candidates for Herceptin (trastuzumab), a commonly used breast cancer treatment. The test, called Inform Dual ISH, allows for measurement of the number of copies of the HER2 [...]
  
  
• Vitamin D Relieves Joint, Muscle Pain For Breast Cancer Patients (0)
  High-dose vitamin D relieves joint and muscle pain for many breast cancer patients taking estrogen-lowering drugs, according to a new study from Washington University School of Medicine in St. Louis. The drugs, known as aromatase inhibitors, are commonly prescribed to shrink breast tumors fueled by the hormone estrogen and help prevent cancer recurrence... Read more [tags] Women's [...]
  
  
• FDA Approves New Test To Help Determine If Breast Cancer Patients Are Candidates For Herceptin Treatment (0)
  The U.S. Food and Drug Administration approved a new genetic test that will help health care professionals determine if women with breast cancer are HER2-positive and, therefore, candidates for Herceptin (trastuzumab), a commonly used breast cancer treatment. The test, called Inform Dual ISH, allows for measurement of the number of copies of [...]
  
  
• Breast cancer drug shows promise for treating, preventing progestin-dependent tumors (0)
  (University of Missouri-Columbia) Recent studies suggest that human breast cancer risk is increased by outside exposure to the hormone progestin, such as during hormone replacement therapy. Now, a University of Missouri study suggests that PRIMA-1, a small molecule drug that targets the most common mutated gene, p53, in human cancer cells, has potential as a [...]
  
  
• Younger Women’s Dense Breast Tissue Limits Effectiveness Of Mammograms, Study Finds (0)
  Mammography alone is not effective for breast cancer screening in women in their 40s because their breast tissue usually appears the same color as tumors in the images, according to a Stanford University study published recently in the Journal of the National Cancer Institute, Newsday/Chicago Tribune reports... Read more [tags] Women's Health [/tags]